Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011854 (
type 1 diabetes
)
20,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Type 1 diabetes is a polygenic disease with a major susceptibility locus,
IDDM1
, located in the human leukocyte antigen (HLA) region. Although class II loci, DR and DQ genes in particular, are major components of
IDDM1
, accumulating lines of evidence indicated that
IDDM1
consists of multiple components and that non-class II genes in addition to class II genes contribute to susceptibility to and/or age-at-onset of
type 1 diabetes
. To identify a second component of
IDDM1
, we investigated the association of a panel of polymorphisms in 2.2 Mb region of the HLA encompassing from class II to class I regions with
type 1 diabetes
. Polymorphisms types were: DRB1 and DQB1 in class II; two microsatellite markers,
BAT2
-GT and TNFa in class III; and, five microsatellite markers, STR-MICA, MIB, C1-3-1, C2-4-4, and C3-2-10 in class I region. A total of >200 Japanese patients and healthy control subjects were studied. Class II DRB1*0405 and DQB1*0401 were significantly associated with susceptibility to, but not with age-at-onset of,
type 1 diabetes
. C1-3-1, located near C locus, was significantly associated with not only susceptibility to, but also age-at-onset of
type 1 diabetes
. These data suggest that a second component of
IDDM1
maps to the HLA class I region, contributing to susceptibility to as well as age-at-onset of
type 1 diabetes
.
...
PMID:A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region. 1713 May 66